October 20, 8:01 AM
BMO Capital analyst Matthew Luchini maintains Entasis Therapeutics Hldg (NASDAQ:ETTX) with a Outperform and raises the price target from $5 to $7.
October 20, 7:05 AM
Gainers Troika Media Group, Inc. (NASDAQ: TRKA) rose 27.3% to $2.05 in pre-market trading after surging around 9% on Tuesday. The company, last month, said it swung to a loss in the fourth quarter.
October 19, 5:36 PM
Zai Lab Highlights Data Out Of Its Partner, Entasis Therapeutics, Related To Topline Results From Sulbactam-Durlobactam Phase 3 ATTACK Trial
October 19, 9:15 AM
SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients Statistically significant difference in clinical cure at Test of Cure vs.
October 19, 7:20 AM
HC Wainwright & Co. analyst Ed Arce maintains Entasis Therapeutics Hldg (NASDAQ:ETTX) with a Buy and raises the price target from $5 to $6.